GlaxoSmithKline Pakistan Limited (PSX:GLAXO)
418.43
+0.75 (0.18%)
At close: Mar 27, 2025
GlaxoSmithKline Pakistan Revenue
In the year 2024, GlaxoSmithKline Pakistan had annual revenue of 61.19B PKR with 23.21% growth. GlaxoSmithKline Pakistan had revenue of 17.59B in the quarter ending December 31, 2024, with 39.22% growth.
Revenue
61.19B
Revenue Growth
+23.21%
P/S Ratio
2.18
Revenue / Employee
35.99M
Employees
1,700
Market Cap
133.31B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 61.19B | 11.53B | 23.21% |
Dec 31, 2023 | 49.66B | 7.82B | 18.69% |
Dec 31, 2022 | 41.84B | 5.18B | 14.13% |
Dec 31, 2021 | 36.66B | 1.57B | 4.48% |
Dec 31, 2020 | 35.09B | -1.49B | -4.08% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Abbott Laboratories (Pakistan) | 68.18B |
AGP Limited | 25.03B |
The Searle Company | 28.80B |
Highnoon Laboratories | 24.63B |
Shifa International Hospitals | 25.45B |
Citi Pharma | 13.19B |
Ferozsons Laboratories | 16.82B |
Otsuka Pakistan | 3.37B |